CASP3 and prostate carcinoma: This study showed that combination treatment of prostate cancer cells with docetaxel and d-limonene can overcome the resistance of prostate cancer cells to apoptosis and that the generation of ROS, activation of caspase-9 and caspase-3 may play a role in enhanced cytotoxicity.